General insurance | Private insurance | p-value | |
---|---|---|---|
n | 925 | 129 | |
Age (years) | 0.06 | ||
Median | 60 | 62 | |
Mean ± SD | 60 ± 10 | 62 ± 11 | |
Sex, n (%) | 0.19 | ||
Male | 731 (79) | 108 (84) | |
Female | 194 (21) | 21 (16) | |
Location, n (%) | 0.52 | ||
Sinonasal | 32 (4) | 3 (2) | |
Nasopharynx | 14 (2) | 5 (4) | |
Oropharynx | 363 (39) | 52 (40) | |
Hypopharynx | 192 (21) | 27 (21) | |
Larynx | 180 (20) | 27 (21) | |
Oral cavity | 140 (15) | 14 (11) | |
CUP | 4 (< 1) | 1 (1) | |
T stage, n (%) | 0.002 | ||
T1/2 | 503 (54) | 87 (67) | |
T3/4 | 418 (45) | 41 (32) | |
N stage, n (%) | 0.86 | ||
N0 | 366 (40) | 50 (39) | |
N+ | 559 (60) | 79 (61) | |
M stage, n (%) | 0.76 | ||
M0 | 886 (96) | 127 (98) | |
M1 | 39 (4) | 2 (2) | |
Grading, n (%) | 0.20 | ||
G1 | 39 (4) | 5 (4) | |
G2 | 452 (49) | 53 (41) | |
G3 | 407 (44) | 62 (48) | |
G4 | 27 (3) | 5 (7) | |
R status, n (%) | 0.24 | ||
R0 | 510 (83) | 78 (80) | |
R1 | 52 (9) | 6 (6) | |
R2 | 11 (2) | 3 (3) | |
Rx | 40 (7) | 10 (10) | |
UICC stage, n (%) | 0.14 | ||
UICC I | 136 (15) | 21 (16) | |
UICC II | 117 (13) | 17 (13) | |
UICC III | 152 (16) | 26 (20) | |
UICC IV | 513 (56) | 63 (49) | |
Therapy, n (%) | 0.31 | ||
Surgery | 164 (18) | 23 (18) | |
Surgery + C/RT | 433 (47) | 69 (54) | |
pC/RT | 328 (35) | 37(29) |